- Home
- SBCF vs CNTA Comparison
SBCF vs CNTA Comparison
Compare SBCF & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBCF
- CNTA
- Stock Information
- Founded
- SBCF 1926
- CNTA 2020
- Country
- SBCF United States
- CNTA United Kingdom
- Employees
- SBCF N/A
- CNTA N/A
- Industry
- SBCF Major Banks
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- SBCF Finance
- CNTA Health Care
- Exchange
- SBCF Nasdaq
- CNTA Nasdaq
- Market Cap
- SBCF 2.7B
- CNTA 2.3B
- IPO Year
- SBCF N/A
- CNTA 2021
- Fundamental
- Price
- SBCF $31.68
- CNTA $22.98
- Analyst Decision
- SBCF Buy
- CNTA Strong Buy
- Analyst Count
- SBCF 4
- CNTA 8
- Target Price
- SBCF $29.50
- CNTA $31.29
- AVG Volume (30 Days)
- SBCF 579.2K
- CNTA 1.2M
- Earning Date
- SBCF 10-27-2025
- CNTA 11-11-2025
- Dividend Yield
- SBCF 2.27%
- CNTA N/A
- EPS Growth
- SBCF 19.16
- CNTA N/A
- EPS
- SBCF 1.63
- CNTA N/A
- Revenue
- SBCF $531,697,000.00
- CNTA $15,000,000.00
- Revenue This Year
- SBCF $28.39
- CNTA N/A
- Revenue Next Year
- SBCF $34.82
- CNTA N/A
- P/E Ratio
- SBCF $19.49
- CNTA N/A
- Revenue Growth
- SBCF 5.40
- CNTA 118.88
- 52 Week Low
- SBCF $21.36
- CNTA $9.60
- 52 Week High
- SBCF $32.33
- CNTA $24.57
- Technical
- Relative Strength Index (RSI)
- SBCF 64.85
- CNTA 59.26
- Support Level
- SBCF $29.61
- CNTA $22.71
- Resistance Level
- SBCF $32.33
- CNTA $23.67
- Average True Range (ATR)
- SBCF 0.79
- CNTA 1.01
- MACD
- SBCF 0.03
- CNTA -0.24
- Stochastic Oscillator
- SBCF 72.11
- CNTA 42.34
About SBCF Seacoast Banking Corporation of Florida
Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage and credit facilities.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.